<DOC>
	<DOCNO>NCT00317135</DOCNO>
	<brief_summary>The purpose study compare reactogenicity &amp; safety Tritanrix™-HepB/Hib-MenAC vaccine international standard care , Tritanrix™-HepB/Hiberix™ .</brief_summary>
	<brief_title>Safety Study Vaccine Against Meningitis Infants ( 2,4 &amp; 6 Months Age ) After Birth Dose Hepatitis B .</brief_title>
	<detailed_description>Randomized study four group receive one follow vaccination regimen dose hepatitis B vaccine give birth : - One 3 lot GSK Biologicals ' Hib-MenAC mixed GSK Biologicals ' Tritanrix™-HepB ( 3 different group ) - GSK Biologicals ' Tritanrix™-HepB/Hiberix™</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criterion study entry : Healthy infant age less equal 3 day age , write informed consent obtain parent , born gestation period 36 42 week . Exclusion criterion study entry : Any confirmed immunodeficient condition , base medical history &amp; physical examination . A family history congenital hereditary immunodeficiency . Major congenital defect serious chronic illness . History neurologic disorder seizure . Administration immunoglobulins and/or blood product since birth plan administration study period . Acute disease time enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>